Sanjay Chanda

Insider Reports History

Entity
Individual
Location
C/O Anacor Pharmaceuticals, Inc., 1020 East Meadow Circle, Palo Alto, CA
Signature
/s/ Lucy Day, Attorney-in-Fact for Sanjay Chanda
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sanjay Chanda:

Stock Role Class Num Shares Value Price $ Report Date Ownership
AN2 Therapeutics, Inc. Chief Development Officer Common Stock 80.1K $107K $1.34 Feb 26, 2025 Direct
AN2 Therapeutics, Inc. Chief Development Officer Stock Option (right to buy) 101K Feb 26, 2025 Direct

Insider Reports Filed by Sanjay Chanda

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ANTX AN2 Therapeutics, Inc. Feb 26, 2025 2 $0 4 Feb 28, 2025 Chief Development Officer
ANTX AN2 Therapeutics, Inc. Jan 3, 2025 1 -$3.97K 4 Jan 7, 2025 Chief Development Officer
ANTX AN2 Therapeutics, Inc. Mar 15, 2024 1 $0 4/A Mar 29, 2024 Chief Development Officer
ANTX AN2 Therapeutics, Inc. Mar 15, 2024 2 $0 4 Mar 18, 2024 Chief Development Officer
ANTX AN2 Therapeutics, Inc. Feb 15, 2023 1 $0 4 Feb 17, 2023 Chief Development Officer
ANTX AN2 Therapeutics, Inc. May 12, 2022 1 $0 4 May 16, 2022 Chief Development Officer
ANTX AN2 Therapeutics, Inc. Mar 24, 2022 0 $0 3 Mar 24, 2022 Chief Development Officer